AmerisourceBergen 2014 Annual Report Download - page 27

Corporate Information
Stockholder Services
Our transfer agent, Computershare, can help you with a variety
of stockholder services, including:
• Change of address
• Lost stock certificates
• Stock transfer
• Account consolidation
Computershare Can Be Reached At:
Telephone: [phone], or TDD 800-231-5469
Outside U.S.: 201-680-6578, or TDD 201-680-6610
Internet: www.computershare.com
Mail: AmerisourceBergen Corporation
c/o Computershare
P.O. Box 43078
Providence, RI 02940-3078
Email: [email protected]
Additional Information
Financial documents, such as our Annual Report on Form
10-K, and quarterly reports on Form 10-Q, and other reports
and filings, such as the Company’s Code of Ethics and Business
Conduct, may be obtained from the Company website at
www.amerisourcebergen.com, or by calling the Company’s
Investor Relations Department at 610-727-7000.
Investor Relations
Stockholders, security analysts, portfolio managers and
other investors desiring further information about the
Company should contact Barbara Brungess, Vice President,
Corporate and Investor Relations at 610-727-7199, or
[email protected].
Annual Meeting of Stockholders
AmerisourceBergen stockholders are invited to attend our
annual meeting on March 5, 2015 at 2:00 p.m. Eastern Time
at The Breakers, One South County Road, Palm Beach, Florida.
Independent Registered Public Accounting Firm
Ernst & Young LLP, Philadelphia, Pennsylvania
Stock Listing
AmerisourceBergen Corporation is listed on The New York
Stock Exchange under the symbol ABC.
Cautionary Note Regarding Forward-Looking Statements
Certain of the statements contained in this Summary Annual Report are “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. Words such as “expect,” “likely,” “outlook,” “forecast,” “would,” “could,”
“should,” “can,” “will,” “project,” “intend,” “plan,” “continue,” “sustain,” “synergy,” “on track,”
“believe,” “seek,” “estimate,” “anticipate,” “may,” “possible,” “assume,” variations of such
words, and similar expressions are intended to identify such forward-looking statements. These
statements are based on management's current expectations and are subject to uncertainty and
change in circumstances. These statements are not guarantees of future performance and are
based on assumptions that could prove incorrect or could cause actual results to vary materially
from those indicated. Among the factors that could cause actual results to differ materially from
those projected, anticipated, or implied are the following: changes in pharmaceutical market
growth rates; price inflation in branded and generic pharmaceuticals and price deflation in generics;
declining economic conditions, increased costs of maintaining, or reductions in AmerisourceBergen’s
ability to maintain, adequate liquidity and financing sources, and interest rate and foreign currency
exchange rate fluctuations; the disruption of AmerisourceBergen’s cash flow and ability to return
value to its stockholders in accordance with its past practices, disruption of or changes in vendor,
payer and customer relationships and terms, and the reduction of AmerisourceBergen’s operational,
strategic or financial flexibility; volatility and disruption of the capital and credit markets; economic,
business, competitive and/or regulatory developments in countries where AmerisourceBergen
does business and/or operates outside of the United States; supplier bankruptcies, insolvencies
or other credit failures; customer bankruptcies, insolvencies or other credit failures; the loss of one
or more key customer or supplier relationships resulting in changes to the customer or supplier
mix; the retention of key customer or supplier relationships under less favorable economics or the
adverse resolution of any contract or other dispute with customers or suppliers; risks associated
with the strategic, long-term relationship between Walgreens Boots Alliance, Inc. (including
its subsidiaries Walgreen Co., Alliance Boots GmbH) and AmerisourceBergen, including the
occurrence of any event, change or other circumstance that could give rise to the termination,
cross-termination or modification of any of the transaction documents among the parties
(including, among others, the distribution agreement or the generics agreement), an impact on
AmerisourceBergen’s earnings per share resulting from the issuance of the warrants to subsidiaries
of Walgreen Boots Alliance, Inc. (the “Warrants”), an inability to realize anticipated benefits
(including benefits resulting from participation in the Walgreens Boots Alliance Development
GmbH joint venture), AmerisourceBergen’s inability to implement its hedging strategy to mitigate
the potentially dilutive effect of the issuance of its common stock under its special share
repurchase program due to its financial performance, the current and future share price of its
common stock, its expected cash flows, competing priorities for capital, and overall market
conditions; increasing governmental regulations regarding the pharmaceutical supply channel;
federal and state government enforcement initiatives to detect and prevent suspicious orders of
controlled substances and the diversion of controlled substances, federal and state prosecution
of alleged violations of related laws and regulations, and any related litigation, including shareholder
derivative lawsuits or other disputes relating to our distribution of controlled substances; changes
in federal and state legislation or regulatory action affecting pharmaceutical product pricing or
reimbursement policies, including under Medicaid and Medicare, and the effect of such changes
on AmerisourceBergen’s customers; frequent changes to laws and regulations in respect of
healthcare fraud and abuse and the increased scrutiny of the federal government related thereto;
qui tam litigation for alleged violations of fraud and abuse laws and regulations and/or any other
laws and regulations governing the marketing, sale, purchase and/or dispensing of pharmaceutical
products or services and any related litigation, including shareholder derivative lawsuits; the
acquisition of businesses that do not perform as AmerisourceBergen expects or that are difficult
for it to integrate or control or AmerisourceBergen's inability to successfully complete any other
transaction that it may wish to pursue from time to time; risks associated with the acquisition of
MWI Veterinary Supply, Inc. (“MWI”), including the anticipated changes in the business environment
in which AmerisourceBergen or MWI operates and in AmerisourceBergen’s future operating results
relating to the potential benefits of a transaction with MWI and the ability of AmerisourceBergen
and MWI to complete the transactions contemplated by the merger agreement, including the
parties’ ability to satisfy the conditions to the transaction set forth in the merger agreement,
uncertainties as to the timing of the tender offer and the subsequent merger, the possibility that
various conditions to the consummation of the tender offer or the merger may not be satisfied
or waived, and the effects of disruption from the transactions on the respective businesses of
AmerisourceBergen and MWI and the fact that the announcement and pendency of the transactions
may make it more difficult to establish or maintain relationships with employees, suppliers and other
business partners; risks associated with international business operations, including non-compliance
with the U.S. Foreign Corrupt Practices Act, anti-bribery laws and economic sanctions and import
laws and regulations; risks generally associated with the sophisticated information systems on
which AmerisourceBergen relies, including significant breakdown or interruption of such systems;
risks generally associated with data privacy regulation and the international transfer of personal
data; changes in tax laws or legislative initiatives that could adversely affect AmerisourceBergen’s
tax positions and/or AmerisourceBergen’s tax liabilities or adverse resolution of challenges to
AmerisourceBergen’s tax positions; natural disasters or other unexpected events that affect
AmerisourceBergen’s operations; and other economic, business, competitive, legal, tax, regulatory
and/or operational factors affecting AmerisourceBergen’s business generally. Certain additional
factors that management believes could cause actual outcomes and results to differ materially
from those described in forward-looking statements are set forth (i) in Item 1A (Risk Factors)
and Item 1 (Business) in the Company’s Annual Report on Form 10-K for the fiscal year ended
September 30, 2014 and elsewhere in that report and (ii) in other reports. 25